Endocrinology, Vol 128, 1496-1504, Copyright © 1991 by Endocrine Society

ARTICLES

Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures

TA Owen, MS Aronow, LM Barone, B Bettencourt, GS Stein and JB Lian
Department of Cell Biology, University of Massachusetts Medical School, Worcester 01655.

Normal rat osteoblasts in culture undergo a developmental sequence consisting of a proliferation period in which high levels of the histone and collagen type I genes are expressed, followed by periods of matrix maturation [high levels of alkaline phosphatase (AP)] and mineralization that signal a high level of production of osteopontin (OP) and osteocalcin (OC). Since these parameters are regulated by vitamin D, the effects of both short term and chronic treatment with 1,25-dihydroxyvitamin D3 were examined during osteoblast growth and differentiation. In acute studies, during the proliferation period, histone mRNA (reflecting DNA synthesis) was inhibited (20-60%). Matrix Gla protein (MGP) and OP mRNA were significantly elevated during proliferation (30- and 15-fold), in contrast to OC which is not expressed and was not induced by hormone treatment. OP and MGP remained stimulated throughout the developmental sequence, but to a lesser degree (from 6- to 10-fold). Collagen and AP mRNA were inhibited by hormone at their peak levels of expression, but were stimulated at their lowest basal levels in the mineralization period. OC expression, which was initiated at the onset of mineralization, was stimulated 13- to 15-fold when basal levels were low, then from 6- to 8-fold by hormone throughout its period of expression. In chronic studies a different profile of gene expression was observed. When hormone treatment was initiated during the proliferation period on day 6, type I collagen and AP expression were suppressed, mineralized nodules did not develop, and induced levels of OP and OC gene expression did not occur. When chronic treatment was initiated on day 20 after the development of a mineralized matrix, OC, but not collagen and OP, levels were stimulated by the hormone. This observation is consistent with the requirement of a competent or mineralized bone matrix for expression of OC. In contrast, MGP expression was stimulated in the chronic vitamin D-treated cultures similar to acute treatments. Taken together these studies demonstrate that vitamin D, a physiological mediator of bone formation and remodelling, can both positively and negatively regulate expression of osteoblast phenotypic markers as a function of duration of hormone treatment and basal levels of gene expression, which is a reflection of bone matrix competency and the differentiated state of the osteoblast.

This article has been cited by other articles:

				S. Zhang, M. Chan, and J. E Aubin Pleiotropic effects of the steroid hormone 1,25-dihydroxyvitamin D3 on the recruitment of mesenchymal lineage progenitors in fetal rat calvaria cell populations. J. Mol. Endocrinol., June 1, 2006; 36(3): 425 - 433. [Abstract] [Full Text] [PDF]

				J. J. Bergh, Y. Shao, E. Puente, R. L. Duncan, and M. C. Farach-Carson Osteoblast Ca2+ permeability and voltage-sensitive Ca2+ channel expression is temporally regulated by 1,25-dihydroxyvitamin D3 Am J Physiol Cell Physiol, March 1, 2006; 290(3): C822 - C831. [Abstract] [Full Text] [PDF]

				G. Duque, M. Macoritto, N. Dion, L.-G. Ste-Marie, and R. Kremer 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6) Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E723 - E730. [Abstract] [Full Text] [PDF]

				A. L. M. Sutton and P. N. MacDonald Vitamin D: More Than a "Bone-a-Fide" Hormone Mol. Endocrinol., May 1, 2003; 17(5): 777 - 791. [Abstract] [Full Text] [PDF]

				A. Gurlek, M. R. Pittelkow, and R. Kumar Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation Endocr. Rev., December 1, 2002; 23(6): 763 - 786. [Abstract] [Full Text] [PDF]

				J. Shen, M. Montecino, J. B. Lian, G. S. Stein, A. J. van Wijnen, and J. L. Stein Histone Acetylation in Vivo at the Osteocalcin Locus Is Functionally Linked to Vitamin D-dependent, Bone Tissue-specific Transcription J. Biol. Chem., May 31, 2002; 277(23): 20284 - 20292. [Abstract] [Full Text] [PDF]

				D. L. Lazarova, M. Bordonaro, and A. C. Sartorelli Transcriptional Regulation of the Vitamin D3 Receptor Gene by ZEB Cell Growth Differ., June 1, 2001; 12(6): 319 - 326. [Abstract] [Full Text] [PDF]

				E. M. GARDINER, P. A. BALDOCK, G. P. THOMAS, N. A. SIMS, N. K. HENDERSON, B. HOLLIS, C. P. WHITE, K. L. SUNN, N. A. MORRISON, W. R. WALSH, et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage FASEB J, October 1, 2000; 14(13): 1908 - 1916. [Abstract] [Full Text]

				H. Drissi, D. Hushka, F. Aslam, Q. Nguyen, E. Buffone, A. Koff, A. J. van Wijnen, J. B. Lian, J. L. Stein, and G. S. Stein The Cell Cycle Regulator p27kip1 Contributes to Growth and Differentiation of Osteoblasts Cancer Res., August 1, 1999; 59(15): 3705 - 3711. [Abstract] [Full Text] [PDF]

				N. Yanaka, H. Akatsuka, E. Kawai, and K. Omori 1,25-Dihydroxyvitamin D3 upregulates natriuretic peptide receptor-C expression in mouse osteoblasts Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E965 - E973. [Abstract] [Full Text] [PDF]

				S. Jono, Y. Nishizawa, A. Shioi, and H. Morii 1,25-Dihydroxyvitamin D3 Increases In Vitro Vascular Calcification by Modulating Secretion of Endogenous Parathyroid Hormone–Related Peptide Circulation, September 29, 1998; 98(13): 1302 - 1306. [Abstract] [Full Text] [PDF]

				P. V. N. Bodine, R. A. Henderson, J. Green, M. Aronow, T. Owen, G. S. Stein, J. B. Lian, and B. S. Komm Estrogen Receptor-{alpha} Is Developmentally Regulated during Osteoblast Differentiation and Contributes to Selective Responsiveness of Gene Expression Endocrinology, April 1, 1998; 139(4): 2048 - 2057. [Abstract] [Full Text] [PDF]

				T. O. Carpenter, K. C. Moltz, B. Ellis, M. Andreoli, T. L. McCarthy, M. Centrella, D. Bryan, and C. M. Gundberg Osteocalcin Production in Primary Osteoblast Cultures Derived from Normal and Hyp Mice Endocrinology, January 1, 1998; 139(1): 35 - 43. [Abstract] [Full Text] [PDF]

				N. A. Sims, C. P. White, K. L. Sunn, G. P. Thomas, M. L. Drummond, N. A. Morrison, J. A. Eisman, and E. M. Gardiner Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo Mol. Endocrinol., October 1, 1997; 11(11): 1695 - 1708. [Abstract] [Full Text]

				J. B. Lian, V. Shalhoub, F. Aslam, B. Frenkel, J. Green, M. Hamrah, G. S. Stein, and J. L. Stein Species-Specific Glucocorticoid and 1,25-Dihydroxyvitamin D Responsiveness in Mouse MC3T3-E1 Osteoblasts: Dexamethasone Inhibits Osteoblast Differentiation and Vitamin D Down-Regulates Osteocalcin Gene Expression Endocrinology, May 1, 1997; 138(5): 2117 - 2127. [Abstract] [Full Text] [PDF]

				R. Zhang, P. Ducy, and G. Karsenty 1,25-Dihydroxyvitamin D3 Inhibits Osteocalcin Expression in Mouse through an Indirect Mechanism J. Biol. Chem., January 3, 1997; 272(1): 110 - 116. [Abstract] [Full Text] [PDF]

				J. R. Nefussi, G. Brami, D. Modrowski, and N. Forest Sequential Expression of Bone Matrix Proteins During Rat Calvaria Osteoblast Differentiation and Bone Nodule Formation In Vitro J. Histochem. Cytochem., January 1, 1997; 45(4): 493 - 504. [Abstract] [Full Text] [PDF]

				Y. Takeuchi, K. Nakayama, and T. Matsumoto Differentiation and Cell Surface Expression of Transforming Growth Factor-beta Receptors Are Regulated by Interaction with Matrix Collagen in Murine Osteoblastic Cells J. Biol. Chem., February 16, 1996; 271(7): 3938 - 3944. [Abstract] [Full Text] [PDF]

				K. A. Hruska and S. L. Teitelbaum Renal Osteodystrophy N. Engl. J. Med., July 20, 1995; 333(3): 166 - 175. [Full Text] [PDF]

				T. Meyer, M. Kneissel, J. Mariani, and B. Fournier In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism PNAS, August 1, 2000; 97(16): 9197 - 9202. [Abstract] [Full Text] [PDF]